RNAI rally underway, page-4

we are grossly undervalued. I sincerely hope any low ball offers of a couple of hundred million dont start coming in. I didn't wait 10 years to be duped.

Post efficacy, there should be no reason whatsoever that we aren't close to a billion dollar market cap at a minimum. If arrowhead can have a market cap of $1b this time last year, then we should be at least near that now.

Can anyone explain to me how the evaluation would work? As in, who would do it, what is taken into account and would efficacy merit a re-rating...